Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]
News [3692]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
mRCC: Closing remarks
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Closing remarks ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity...
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Optimizing survival in advanced prostate cancer: Welcome and introduction
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Welcome and introduction ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to...
Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
29 Jan 2015
Optimizing Survival in Advanced Prostate Cancer: Conclusion
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing Survival in Advanced Prostate Cancer: Conclusion ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Cancer cell models for improved therapies
Dr Mathew Garnett, Wellcome Trust Sanger Institute, Cambridge, UK
Cancer cell models for improved therapies ( Dr Mathew Garnett, Wellcome Trust Sanger Institute, Cambridge, UK )
6 Jan 2015
UICC 2014 conference report
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
UICC 2014 conference report ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Dec 2014
Comment: SABCS 2014 Highlights
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: SABCS 2014 Highlights ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )
16 Dec 2014
Comment: Multigene test can predict risk of disease recurrence for women with...
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )
16 Dec 2014
CLL at ASH 2014: Expert discussion
Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014
Best of ASH 2014
Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert...
Best of ASH 2014 ( Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele )
8 Dec 2014
ASH 2014: Highlights in CLL from ASH 2014
Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger
ASH 2014: Highlights in CLL from ASH 2014 ( Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger )
8 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation